Organiser: The Alan Turing Institute

The Turing-Roche strategic partnership is a collaboration in advanced analytics between Roche and the Turing, focused on enabling the transformative benefits of personalised healthcare to become a reality for patients around the world. The Turing-Roche knowledge share series brings together members of Roche and Turing's networks to showcase partnership research and share knowledge. 

This event will be on the theme of AI in precision medicine. We will explore how AI's insights may help each patient's unique needs and empower clinician decision-making. The event speakers are Dr Samaneh Abbasi, Senior Data Scientist and Data Science Network Co-Lead on the PHC Data analytics and Imaging (DAI) team at Roche and Professor Zoe Kourtzi, Professor of Cognitive Computational Neuroscience at the University of Cambridge and Turing University Lead.
 
Samaneh will speak about automatic detection of molecular subtypes as one of the prognostic factors in breast cancer directly from H&E images, while in clinics IHC staining is usually used to determine this factor.
 
Zoe will discuss the EDoN initiative which brings together global experts in data science, digital technology and neurodegeneration to develop a digital tool for the early detection of diseases that cause dementia.

This is an online event aimed at a technical audience. For further details and to register, please visit: The Turing-Roche knowledge share series: AI in precision medicine | The Alan Turing Institute.